A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...
New research has found that women have a higher risk of developing cardiovascular issues, including stroke and heart failure, ...
Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback